Findings could open up new avenue for precision therapy for the most commonly diagnosed cancer among women that killed 670,000 in 2022 alone A team of Chinese scientists has uncovered a key mechanism ...

Chinese scientists have revealed a hidden metabolic partnership between breast cancer cells and immune cells that drives aggressive tumor behavior and resistance to immunotherapies. The study sheds ...

Researchers have revealed a hidden metabolic partnership between breast cancer cells and immune cells that drives aggressive ...

The top-line results from the ATOMIC-Meso study are nothing short of tremendous leveraging a novel area of cancer metabolism for patients by targeting arginine, specifically in non-epithelioid ...

Polaris Pharmaceuticals is evaluating its lead therapeutic protein—pegargiminase, a novel targeted cancer therapy that depletes circulating arginine—in combination with standard chemotherapies ...

Marlieke Visser; Walter J. Paulus; Mechteld A.R. Vermeulen; Milan C. Richir; Mariska Davids; Willem Wisselink; Bas A.J.M. de Mol; Paul A.M. van Leeuwen ...

They also found that disrupting arginine metabolism could help restore the activity of the T cells and slow tumour growth. “These findings highlight the potential of targeting arginine metabolic ...